|
1
|
Barroso B: Decompressive craniectomy for
stroke after intravenous thombolytic therapy. Int J Stroke.
9:E402014. View Article : Google Scholar
|
|
2
|
Yang J, Zheng M, Chen S, et al: Knowledge
of thrombolytic therapy for acute ischemic stroke among community
residents in western urban China. PLoS One. 9:e1078922014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gargiulo S, Sottero B, Gamba P, Chiarpotto
E, Poli G and Leonarduzzi G: Plaque oxysterols induce unbalanced
up-regulation of matrix metalloproteinase-9 in macrophagic cells
through redox-sensitive signaling pathways: Implications regarding
the vulnerability of atherosclerotic lesions. Free Radic Biol Med.
51:844–855. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pan CL and Zheng LF: Relationship of
lysophosphatidic acid and matrix metalloproteinase-9 with carotid
atheromatous plaque stability in patients with cerebral infarction.
Zhonghua Lao Nian Yi Xue Za Zhi. 29:115–118. 2010.(In Chinese).
|
|
5
|
Pöllänen PJ, Karhunen PJ, Mikkelsson J, et
al: Coronary artery complicated lesion area is related to
functional polymorphism of matrix metalloproteinase 9 gene: an
autopsy study. Arterioscler Thromb Vasc Biol. 21:1446–1450. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chinese Neuroscience, Chinese Academy of
Neuroscience. Various types of cerebrovascular disease diagnostic
criteria. Zhonghua Shen Jing Ke Za Zhi. 29:379–380. 1996.(In
Chinese).
|
|
7
|
Ahmad NN, Cu-Unjieng AB and Donoso LA:
Modification of standard proteinase K/phenol method for DNA
isolation to improve yield and purity from frozen blood. J Med
Genet. 32:129–130. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cao XH, Liu M and Wu B: Relationship
between plasma matrix metalloproteinase-9 and hemorrhagic
transformation in ischemic stroke: a systematic review. Zhongguo
Xun Zheng Yi Xue Za Zhi. 6:361–369. 2006.(In Chinese).
|
|
9
|
Hou H, Zhang G, Wang H, Gong H, Wang C and
Zhang X: High matrix metalloproteinase-9 expression induces
angiogenesis and basement membrane degradation in stroke-prone
spontaneously hypertensive rats after cerebral infarction. Neural
Regen Res. 9:1154–1162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sarrafzadeh A, Copin JC, Bengualid DJ, et
al: Matrix metalloproteinase-9 concentration in the cerebral
extracellular fluid of patients during the acute phase of
aneurysmal subarachnoid hemorrhage. Neurol Res. 34:455–461. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang X and Shi LZ: Association of matrix
metalloproteinase-9 C1562T polymorphism and coronary artery
disease: a meta-analysis. J Zhejiang Univ Sci B. 15:256–263. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schveigert D, Valuckas KP, Kovalcis V,
Ulys A, Chvatovic G and Didziapetriene J: Significance of MMP-9
expression and MMP-9 polymorphism in prostate cancer. Tumori.
99:523–529. 2013.PubMed/NCBI
|
|
13
|
Xiao Z, Liu Q, Mao F, Wu J and Lei T:
TNF-α-induced VEGF and MMP-9 expression promotes hemorrhagic
transformation in pituitary adenomas. Int J Mol Sci. 12:4165–4179.
2011. View Article : Google Scholar
|
|
14
|
Montaner J, Molina CA, Monasterio J, et
al: Matrix metalloproteinase-9 pretreatment level predicts
intracranial hemorrhagic complications after thrombolysis in human
stroke. Circulation. 107:598–603. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang XB, Wang JS, Liu DH, Yuan WS and Shi
ZS: Overexpression of matrix metalloproteinase-9 is correlated with
carotid intraplaque hemorrhage in a swine model. J Neurointerv
Surg. 5:473–477. 2013. View Article : Google Scholar
|
|
16
|
Goracy J, Goracy I, Brykczyński M,
Peregud-Pogorzelska M, Naruszewicz M and Ciechanowicz A: The
C(−1562)T polymorphism in the promoter of the matrix
metalloproteinase-9 (MMP-9) gene and coronary atherosclerosis. Pol
Arch Med Wewn. 110:1275–1281. 2003.(In Polish).
|
|
17
|
Szczudlik P and Borratyńska A: Association
between the −1562 C/T MMP-9 polymorphism and cerebrovascular
disease in a Polish population. Neurol Neurochir Pol. 44:350–357.
2010.PubMed/NCBI
|
|
18
|
Fernández-Cadenas I, Del Río-Espínola A,
Carrera C, et al: Role of the MMP9 gene in hemorrhagic
transformations after tissue-type plasminogen activator treatment
in stroke patients. Stroke. 43:1398–1400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang LJ, Chen XF, Zhu M, Shen WF and Jiang
JJ: Study of relations between matrix metalloproteinase-9
polymorphism (C−1562T) and acute coronary syndrome in Han
population of China. Zhonghua Yi Xue Yi Chuan Xue Za Zhi.
22:313–316. 2005.(In Chinese). PubMed/NCBI
|
|
20
|
Song WH, Dang AM, Zhu JM, Lü NQ, Liu GZ
and Hui RT: MMP-9 gene −1562C/T polymorphism in aortic dissection
in Chinese hypertensive patients. Zhonghua Nei Ke Za Zhi.
45:376–378. 2006.(In Chinese). PubMed/NCBI
|
|
21
|
Duellman T, Warren CL, Peissig P, Wynn M
and Yang J: Matrix metalloproteinase-9 genotype as a potential
genetic marker for abdominal aortic aneurysm. Circ Cardiovasc
Genet. 5:529–537. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xing LL, Wang ZN, Jiang L, et al: Matrix
metalloproteinase-9−1562C>T polymorphism may increase the risk
of lymphatic metastasis of colorectal cancer. World J
Gastroenterol. 13:4626–4629. 2007.PubMed/NCBI
|
|
23
|
Xin DD, Chen ZB, Liu XP, et al:
Association of functional −1562C/T polymorphism in matrix
metalloproteinase-9 (MMP-9) with risk of severe encephalitis in
enterovirus 71 infected children. Xian Dai Sheng Wu Yi Xue Jin
Zhan. 15:2870–2874. 2013.(In Chinese).
|
